+ Watch VPHM
on My Watchlist
A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.
NO SOLID PHASE 3 TRIALS.HAVE MANY FAILURES IN THE PIPELINE; ALOT OF COMPETETION FOR HEP C, INCLUDING INGENIX AND SCHERING WITH PROTEASE INHIBITORS COMING OUT. NEED NEW BLOOD COARSING THROUGH ITS VEINS OR COULD SETTLE IN AT 11-13.
another perfectly good review ruined because of all caps,,,reminds me of an old teletype with only one type face....http://www.youtube.com/watch?v=eyCEexG9xjw
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions